---
figid: PMC6499928__nihms-1025294-f0001
figlink: /pmc/articles/PMC6499928/figure/F1/
number: Fig. 1
caption: Schema of multiple pathway targets in CRC described in the review. Also illustrated
  is the T cell and its multiple points of interaction with CRC cells which can be
  exploited therapeutically. Arrows refer to agonistic binding while the “—|” symbols
  refer to inhibition.
pmcid: PMC6499928
papertitle: Promising New Agents for Colorectal Cancer.
reftext: Satya Das, et al. Curr Treat Options Oncol. 2018 May 11;19(6):29-29.
pmc_ranked_result_index: '115119'
pathway_score: 0.9458077
filename: nihms-1025294-f0001.jpg
figtitle: Schema of multiple pathway targets in CRC described in the review
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6499928__nihms-1025294-f0001.html
  '@type': Dataset
  description: Schema of multiple pathway targets in CRC described in the review.
    Also illustrated is the T cell and its multiple points of interaction with CRC
    cells which can be exploited therapeutically. Arrows refer to agonistic binding
    while the “—|” symbols refer to inhibition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD247
  - PDCD1
  - CD3D
  - MAP2K2
  - CD3E
  - CD274
  - ARAF
  - EGFR
  - CD3G
  - RAF1
  - CTLA4
  - ERBB2
  - MAP2K1
  - CEACAM5
  - KRAS
  - NRAS
  - BRAF
  - HRAS
  - MAPK1
  - MAPK3
  - XPO1
  - Lapatinib
  - Glutamine
  - Selumetinib
  - Encorafenib
  - Binimetinib
  - Dabrafenib
  - Trametinib
  - SINE
genes:
- word: CD-3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD247
  entrez: '919'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: CD-3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3D
  entrez: '915'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: CD-3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3E
  entrez: '916'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: CD-3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3G
  entrez: '917'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: HER-2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: CEA
  symbol: CEA
  source: hgnc_prev_symbol
  hgnc_symbol: CEACAM5
  entrez: '1048'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: XPO-1/
  symbol: XPO1
  source: hgnc_symbol
  hgnc_symbol: XPO1
  entrez: '7514'
chemicals:
- word: Lapatinib
  source: MESH
  identifier: C490728
- word: Glutamine
  source: MESH
  identifier: C578860
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: Encorafenib
  source: ''
  identifier: ''
- word: Binimetinib
  source: MESH
  identifier: C581313
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: Trametinib
  source: MESH
  identifier: C560077
diseases:
- word: SINE
  source: ''
  identifier: ''
---
